Six weeks antibiotic therapy for all bone infections: Results of a cohort study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 2, 2010, Pages 217-222

  Farhad, R ^a   Roger, P M ^a   Albert, C ^b   Pelligri C ^b   Touati, C ^b   Dellamonica, P ^a   Trojani, C ^b   Boileau, P ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; OFLOXACIN; OXACILLIN; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; TIMENTIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ARTHRITIS; BONE BIOPSY; BONE INFECTION; COHORT ANALYSIS; DRUG HYPERSENSITIVITY; ENTEROBACTERIACEAE; FEMALE; FOLLOW UP; FOREIGN BODY; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; NEUROLOGIC DISEASE; OSTEOARTHRITIS; OSTEOMYELITIS; OSTEOSYNTHESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPONDYLITIS; STREPTOCOCCUS; TREATMENT DURATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BONE DISEASES, INFECTIOUS; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 77249101980     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0842-1     Document Type: Article

References (25)

1. S Nasser 1994 The incidence of sepsis after total hip replacement arthroplasty Semin Arthroplasty 5 153 159 1:STN:280:DyaK28%2FjvVSlug%3D%3D 10155158
2. AD Hanssen JA Rand 1998 Evaluation and treatment of infection at the site of a total hip or knee arthroplasty Instr Course Lect 48 111 122
3. DP Lew FA Waldvogel 1997 Osteomyelitis N Engl J Med 336 999 1007 10.1056/NEJM199704033361406 1:STN:280:DyaK2s3it1ertg%3D%3D 9077380 (Pubitemid 27152787)
4. DP Lew FA Waldvogel 2004 Osteomyelitis Lancet 364 369 379 10.1016/S0140-6736(04)16727-5 1:CAS:528:DC%2BD2cXmtVSktbc%3D 15276398 (Pubitemid 38976521)
5. TP Sculco 1993 The economic impact of infected total joint arthroplasty Instr Course Lect 42 346 351
6. C Pulcini T Couadau E Bernard, et al. 2008 Adverse effects of parenteral antimicrobial therapy for chronic bone infections Eur J Clin Microbiol Infect Dis 27 1227 1232 10.1007/s10096-008-0570-y 1:STN:280:DC%2BD1cjktF2htw%3D%3D 18818959
7. D Stengel K Bauwens J Sehouli, et al. 2001 Systematic review and meta-analysis of antibiotic therapy for bone and joint infections Lancet Infect Dis 1 175 188 10.1016/S1473-3099(01)00094-9 1:CAS:528:DC%2BD38XltVOntr4%3D 11871494 (Pubitemid 33586051)
8. W Zimmerli A Trampuz PE Ochsner 2004 Prosthetic-joint infections N Engl J Med 351 1645 1654 10.1056/NEJMra040181 1:CAS:528:DC%2BD2cXos1Whtbo%3D 15483283 (Pubitemid 39350425)
9. L Lazzarini BA Lipsky JT Mader 2005 Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 9 127 138 10.1016/j.ijid.2004.09.009 1:CAS:528:DC%2BD2MXltlSgsLs%3D 15840453 (Pubitemid 40523757)
10. I Williams WA Venables D Lloyd, et al. 1997 The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus Microbiology 143 2407 2413 10.1099/00221287-143-7-2407 1:CAS:528: DyaK2sXkvFKjs74%3D 9245822
11. I Williams F Paul D Lloyd, et al. 1999 Flow cytometry and other techniques show that Staphylococcus aureus undergoes significant physiological changes in the early stages of surface-attached culture Microbiology 145 1325 1333 10.1099/13500872-145-6-1325 1:CAS:528:DyaK1MXktFWnuro%3D 10411259
12. SG Giulieri P Graber P Ochsner, et al. 2004 Management of infection associated with total hip arthroplasty according to a treatment algorithm Infection 32 222 228 10.1007/s15010-004-4020-1 1:STN:280:DC%2BD2czovVWiug%3D%3D 15293078
13. JS Butler MJ Shelly M Timlin, et al. 2006 Nontuberculous pyogenic spinal infection in adults: a 12-year experience from a tertiary referral center Spine 31 2695 2700 10.1097/01.brs.0000244662.78725.37 17077738 (Pubitemid 44673381)
14. N Le Saux A Howard NJ Barrowman, et al. 2002 Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review BMC Infect Dis 2 16 25 10.1186/1471-2334-2-16 12181082 (Pubitemid 38750900)
15. AF Zuluaga W Galvis JG Saldarriaga, et al. 2006 Etiologic diagnosis of chronic osteomyelitis: a prospective study Arch Intern Med 166 95 100 10.1001/archinte.166.1.95 16401816 (Pubitemid 43063847)
16. S Weichert M Sharland NM Clarke, et al. 2008 Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis 21 258 262 10.1097/QCO.0b013e3283005441 18448970 (Pubitemid 351620380)
17. F Roblot JM Besnier L Juhel, et al. 2007 Optimal duration of antibiotic therapy in vertebral osteomyelitis Semin Arthritis Rheum 36 269 277 10.1016/j.semarthrit.2006.09.004 1:CAS:528:DC%2BD2sXjvFOntLc%3D 17207522 (Pubitemid 46517630)
18. H Peltola M Pääkkönen P Kallio Osteomyelitis-Septic Arthritis (OM-SA) Study Group, et al. 2009 Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis Clin Infect Dis 48 1201 1210 10.1086/597582 1:CAS:528:DC%2BD1MXlsFWluro%3D 19323633
19. GL Pavoni M Giannella M Falcone, et al. 2004 Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience Clin Microbiol Infect 10 831 837 10.1111/j.1469-0691.2004.00928.x 1:CAS:528:DC%2BD2cXptFGksbo%3D 15355415 (Pubitemid 39276318)
20. W Zimmerli AF Widmer M Blatter, et al. 1998 Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group JAMA 279 1537 1541 10.1001/jama.279.19.1537 1:CAS:528:DyaK1cXjs1ygurk%3D 9605897 (Pubitemid 28233008)
21. Y El Samad E Havet H Bentayeb, et al. 2008 Treatment of osteoarticular infections with clindamycin in adults Med Mal Infect 38 465 470 10.1016/j.medmal.2008.06.030 18718729
22. JC Dombrowski LG Winston 2008 Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections J Infect 57 110 115 10.1016/j.jinf.2008.04.003 18533269
23. E Bernard I Perbost M Carles, et al. 1997 Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic Gram-positive bone and joint infections Clin Microbiol Infect 3 440 446 10.1111/j.1469-0691.1997. tb00280.x 1:CAS:528:DyaK2sXmtVGhtrY%3D 11864154
24. AD Tice PA Hoaglund DA Shoultz 2003 Risk factors and treatment outcomes in osteomyelitis J Antimicrob Chemother 51 1261 1268 10.1093/jac/dkg186 1:CAS:528:DC%2BD3sXjsVKls7s%3D 12668581 (Pubitemid 36622083)
25. AR Berendt EJ Peters K Bakker, et al. 2008 Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment Diabetes Metab Res Rev 24 Suppl 1 S145 S161 10.1002/dmrr.836 18442163 (Pubitemid 351802786)